{"id":"W2808981859","doi":"10.2337/db18-301-or","title":"Similar Glycemic Control and Less or Comparable Hypoglycemia with Insulin Glargine 300 U/mL (Gla-300) vs. Degludec 100 U/mL (IDeg-100) in Insulin-Naïve T2DM on Antihyperglycemic Drugs ± GLP-1 RAs—The BRIGHT Randomized Study","year":2018,"lang":"en","type":"article","venue":"Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Insulin degludec; Hypoglycemia; Glycemic; Insulin glargine; Insulin; Internal medicine; Endocrinology; Clinical endpoint; Adverse effect; Randomized controlled trial","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002759557,0.0009402175,0.002485937,0.0005994795,0.000277072,0.001466084,0.0006539579,0.001561136,0.004965856],"category_scores_gemma":[0.001792575,0.000482058,0.002278591,0.0004359785,0.0007753389,0.001343727,0.0003712228,0.002436474,0.0006808885],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003553952,"about_ca_system_score_gemma":0.0006816779,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004946183,"about_ca_topic_score_gemma":0.0008305281,"domain_scores_codex":[0.999138,0.0004879627,0.00007941412,0.0001094226,0.00006111802,0.0001240545],"domain_scores_gemma":[0.9989958,0.000314938,0.0001626148,0.0001329247,0.00004333527,0.0003504536],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9639168,0.01182595,0.0004418958,0.0003235175,0.0006655072,0.00004011984,0.00003025546,0.0002464275,0.005469267,0.000104756,0.0005497328,0.01638583],"study_design_scores_gemma":[0.7219676,0.2684837,0.005561631,0.0000416471,0.0008482541,0.00006216168,0.00004227895,0.0005795018,0.001392058,0.0003048593,0.0006875076,0.00002879206],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923154,0.002492524,0.0004808916,0.0004164648,0.0005273136,0.0006165834,0.0007085365,0.0001142213,0.002328018],"genre_scores_gemma":[0.9929675,0.001394105,0.000955699,0.0009604181,0.0005285066,0.0003882524,0.001033804,0.00003801105,0.001733829],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004965856,"threshold_uncertainty_score":0.01661241,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01320363971060372,"score_gpt":0.2518104125333624,"score_spread":0.2386067728227587,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}